Literature DB >> 25504623

Furin-mediated sequential delivery of anticancer cytokine and small-molecule drug shuttled by graphene.

Tianyue Jiang1, Wujin Sun, Qiuwen Zhu, Nancy A Burns, Saad A Khan, Ran Mo, Zhen Gu.   

Abstract

A cellular protease (furin)-mediated graphene-based nanosystem is developed for co-delivery of a membrane-associated cytokine (tumor-necrosis-factor-related apoptosis-inducing ligand, TRAIL) and an intracellular-acting small-molecule drug (Doxorubicin, DOX). TRAIL and DOX can be sequentially released toward the plasma membrane and nucleus, respectively.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cytokine; drug delivery; furin; graphene oxide; nanomedicine

Mesh:

Substances:

Year:  2014        PMID: 25504623      PMCID: PMC5769919          DOI: 10.1002/adma.201404498

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  51 in total

1.  Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.

Authors:  Nagesh Kolishetti; Shanta Dhar; Pedro M Valencia; Lucy Q Lin; Rohit Karnik; Stephen J Lippard; Robert Langer; Omid C Farokhzad
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL.

Authors:  S B Gibson; R Oyer; A C Spalding; S M Anderson; G L Johnson
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Endoprotease-mediated intracellular protein delivery using nanocapsules.

Authors:  Anuradha Biswas; Kye-Il Joo; Jing Liu; Muxun Zhao; Guoping Fan; Pin Wang; Zhen Gu; Yi Tang
Journal:  ACS Nano       Date:  2011-01-26       Impact factor: 15.881

4.  Advances in Anticancer Protein Delivery Using Micro-/ Nanoparticles.

Authors:  Wujin Sun; Yue Lu; Zhen Gu
Journal:  Part Part Syst Charact       Date:  2014-10-16       Impact factor: 3.310

5.  The receptor for the cytotoxic ligand TRAIL.

Authors:  G Pan; K O'Rourke; A M Chinnaiyan; R Gentz; R Ebner; J Ni; V M Dixit
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

6.  Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors.

Authors:  Gerald Batist; Karen A Gelmon; Kim N Chi; Wilson H Miller; Stephen K L Chia; Lawrence D Mayer; Christine E Swenson; Andrew S Janoff; Arthur C Louie
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

7.  Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia.

Authors:  Young Joo Min; Je-Hwan Lee; Seong-Jun Choi; Hyun-Sook Chi; Jung-Shin Lee; Woo-Kun Kim; Kyoo-Hyung Lee
Journal:  Leuk Res       Date:  2004-04       Impact factor: 3.156

Review 8.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

9.  Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.

Authors:  Jin H Song; Margaret C L Tse; Anita Bellail; Surasak Phuphanich; Fadlo Khuri; Norman M Kneteman; Chunhai Hao
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

10.  Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs.

Authors:  Liming Zhang; Jingguang Xia; Qinghuan Zhao; Liwei Liu; Zhijun Zhang
Journal:  Small       Date:  2010-02-22       Impact factor: 13.281

View more
  44 in total

Review 1.  Nanoformulations for combination or cascade anticancer therapy.

Authors:  Lei Miao; Shutao Guo; C Michael Lin; Qi Liu; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2017-06-15       Impact factor: 15.470

Review 2.  Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.

Authors:  Fanfei Meng; Ning Han; Yoon Yeo
Journal:  Expert Opin Drug Deliv       Date:  2016-08-08       Impact factor: 6.648

3.  The encapsulation of the gemcitabine anticancer drug into grapheme nest: a theoretical study.

Authors:  Marwa Mlaouah; Bahoueddine Tangour; Mohammed El Khalifi; Tijani Gharbi; Fabien Picaud
Journal:  J Mol Model       Date:  2018-03-22       Impact factor: 1.810

4.  Intracellular Mechanistic Understanding of 2D MoS2 Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy.

Authors:  Xianbing Zhu; Xiaoyuan Ji; Na Kong; Yunhan Chen; Morteza Mahmoudi; Xiaoding Xu; Li Ding; Wei Tao; Ting Cai; Yujing Li; Tian Gan; Austin Barrett; Zameer Bharwani; Hongbo Chen; Omid C Farokhzad
Journal:  ACS Nano       Date:  2018-03-12       Impact factor: 15.881

Review 5.  Nanomedicines for renal disease: current status and future applications.

Authors:  Nazila Kamaly; John C He; Dennis A Ausiello; Omid C Farokhzad
Journal:  Nat Rev Nephrol       Date:  2016-10-31       Impact factor: 28.314

Review 6.  Opportunities and challenges in combination gene cancer therapy.

Authors:  Kent L Nastiuk; John J Krolewski
Journal:  Adv Drug Deliv Rev       Date:  2015-12-23       Impact factor: 15.470

7.  A dual wavelength-activatable gold nanorod complex for synergistic cancer treatment.

Authors:  Dennis B Pacardo; Bhanu Neupane; S Michaela Rikard; Yue Lu; Ran Mo; Sumeet R Mishra; Joseph B Tracy; Gufeng Wang; Frances S Ligler; Zhen Gu
Journal:  Nanoscale       Date:  2015-06-30       Impact factor: 7.790

8.  ATP-responsive DNA-graphene hybrid nanoaggregates for anticancer drug delivery.

Authors:  Ran Mo; Tianyue Jiang; Wujin Sun; Zhen Gu
Journal:  Biomaterials       Date:  2015-02-14       Impact factor: 12.479

9.  ATP-Responsive Drug Delivery Systems.

Authors:  Wujin Sun; Zhen Gu
Journal:  Expert Opin Drug Deliv       Date:  2016-02-01       Impact factor: 6.648

10.  Cytosolic Delivery of Functional Proteins In Vitro through Tunable Gigahertz Acoustics.

Authors:  Shuting Pan; Taewon Jeon; David C Luther; Xuexin Duan; Vincent M Rotello
Journal:  ACS Appl Mater Interfaces       Date:  2020-03-18       Impact factor: 9.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.